How Can We Improve Antimicrobial Stewardship in Solid Organ Transplant Patients?

Strategic Alliance Partners | <b>Society of Infectious Diseases Pharmacists</b>

Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, discusses how collaboration with transplant counterparts is needed to provide optimal treatment.

Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, discusses how collaboration with transplant counterparts is needed to provide optimal treatment.

Interview Transcript (slightly modified for readability)

“Increased collaboration with our transplant counterparts, [is needed] so that we [as infectious disease pharmacists] can gather more data and have more information on the optimal treatment of these patients, be it duration of therapy, what we should be using for impaired therapy, combination therapy, and how these therapies impact the immunosuppression of the patients in terms of drug [to] drug interactions.”